| Shi et al., 2017103
|
100% of human type II alveolar
epithelial cells were alive 4 h after the treatment for concentrations
up to 50 μg/mL, while at 100 μg/mL a significant reduction
was recorded. |
in vitro |
| Zheng et al., 2017104
|
Viability was above 80%
up to 1000 μg/mL for human mesenchymal stem cells. |
in vitro |
| Amorim et al., 201945
|
Cashew gum-stabilized CuNPs
on murine macrophages and murine fibroblast cells, above 80% even
up to 1000 μg/mL. |
in vitro |
| Zhou et al., 202090
|
CuS hydrogels
after 48 h
on mouse embryonic fibroblasts, above 80% even up to 1000 μg/mL. |
in vitro |
| Yin et al., 2017109
|
GSH-CuNPs persisted mostly
in the bladder for the first hours, with rapid clearing of the metal
complex to urine. |
injection |
| Yang et al., 2015110
|
78.5% ID of glutathione-CuNPs
was excreted through the urine in the first 24 h, and 22% ID of the
Cu(II)complexes was found in the urine. After 24 h, about 30% ID of
the Cu(II)complex was in the liver and up to 0.9% ID was present in
the kidneys, lowering to 0.6% ID in brain and 0.3% ID in lungs. |
injection |
| Liang et al., 2017111
|
After 24 h, only 7.7% ID
and 3.3% ID accumulated in liver and kidneys, respectively; also detected
in the heart, slowly disappearing after 2 h. |
injection |
| Han et
al., 2019114
|
Ultrasmall copper selenide
NPs, 10 mg/kg, are eliminated mostly in urine and feces in 6–12
h (29.2% and 36.7%, respectively). In the first 2 h, Cu2–xSe was found located mostly in the kidneys (12.1
μg/g of tissue), then decreased at 72 h (2 μg/g of tissue). |
injection |
| Feng et al., 2015115
|
120 nm CuS nanoplates at
a concentration of 5.5 mg/kg; levels in liver and kidneys increased
to 1.6 and 0.9 μg/g at 4 h. |
injection |
| Dey et al., 2019116
|
Hepatotoxicity was also
found on mice orally treated with up to 6.5 mg/kg of 40–60
nm CuNPs in a diet for 4 weeks. |
orally |
| Lei et al., 2015118
|
Liver
damage in mice orally
treated with a shorter regime but with a higher dose of NPs (5 days,
200 mg kg–1 d–1 of CuNPs). |
orally |
| Cholewińska et al., 2018117
|
Accumulation of copper in
the brain of mice after a 4 weeks of CuNPs diet; higher with respect
to the carbonate-based diet. |
orally |
| Fahmy et al., 2020119
|
Accumulation in all brain
areas, except the medulla and mid brain; hippocampus contained 0.04
mg of copper per gram of tissue. |
intranasal |
| Shi et al., 2020125
|
Increase
in primary components
of β-amyloid plaques in vitro. |
in vitro |
| Sandhya Rani et
al., 2013128
|
After inhalation, a certain
degeneration of lungs, fibrosis, and granuloma. |
inhalation |